Live Breaking News & Updates on Indaa johnson

Stay informed with the latest breaking news from Indaa johnson on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Indaa johnson and stay connected to the pulse of your community

AP source: J&J doses to be released, but many will be tossed

U.S. regulators are allowing the release of 10 million doses of Johnson & Johnson's...

United-states , United-kingdom , Netherlands , American , British , Astrazeneca , Emergent-biosolutions , J , Eter-marks , Mergent , Indaa-johnson

J&J vaccine doses to be released, but many will be tossed

U.S. regulators are allowing the release of about 10 million doses of Johnson &...

United-states , Netherlands , United-kingdom , American , British , Lindaa-johnson , Peter-marks , Matthew-perrone , Astrazeneca , Science-department , Associated-press , Emergent-biosolutions

Houston doctor weighs in on new FDA approved obesity drug

A new version of a popular diabetes medicine could be sold as a weight-loss drug in the...

Maryland , United-states , Houston , Texas , Denmark , Danish , Lindaa-johnson , Phylander-pannell , Novo-nordisk-victoza , Science-department , Atherosclerosis-research-center , Obesity-medicine-association

FDA OKs 1st targeted drug for common lung cancer mutation

FDA OKs 1st targeted drug for common lung cancer mutation
LINDA A. JOHNSON, AP Medical Writer
May 28, 2021
FacebookTwitterEmail
This image provided by Amgen in May 2021 shows packaging for their medication Lumakras. On Friday, May 28, 2021, the U.S. Food and Drug Administration approved Lumakras, the first medicine for adults with advanced non-small cell lung cancer whose tumors have a common genetic mutation long considered untreatable with drugs. Each year, about 13,000 U.S. patients are diagnosed with this cancer and mutation. (Amgen via AP)AP
FAIRLESS HILLS, PA. (AP) — U.S. regulators have approved the first medicine for patients with the most common type of lung cancer whose tumors have a genetic mutation long considered untreatable with drugs.

Lindaa-johnson , Richard-pazdur , Davidm-reese , Amgen , Oncology-center , Science-department , Associated-press-health , Howard-hughes-medical-institute , Ichard-pazdur , Umakras , Indaa-johnson , Nited-states

Unsure vaccine waiver will help, some leaders urge exports

GENEVA (AP) — European leaders voiced increasing skepticism Friday that a U.S. proposal...

Germany , Mexico , United-states , Rome , Lazio , Italy , Washington , White-house , District-of-columbia , Portugal , South-africa , Cape-town

Pfizer ups expectations for the year

Vaccine sales power Pfizer through first quarter
LINDA A. JOHNSON, AP Medical Writer
May 4, 2021
FacebookTwitterEmail
5
1of5FILE - In this April 14, 2021 file photo, a Northwell Health nurse injects Local 28 Sheet Metal Worker Demetrius Buttelman with the first dose of the Pfizer vaccine during a news conference, at the Belmont Park in Elmont, N.Y. The state recorded 43,000 new cases in the week that ended Saturday, April 17, 2021. That's the lowest number in a seven-day period since Thanksgiving.Mary Altaffer/APShow MoreShow Less
2of5Gov. Andrew Cuomo embraces Radhames Rodriguez, President of United Bodegas of America, after Rodriguez received a Pfizer COVID-19 vaccination shot at an event to announce five new walk-in pop-up COVID-19 vaccination sites for New York Bodega, grocery store and supermarket workers in the Harlem section of New York on Friday, April 23, 2021. (Mike Segar/Pool Photo via AP)Mike Segar/APShow MoreShow Less

Germany , New-york , United-states , German , Radhames-rodriguez , Andrew-cuomo , Biontech-corona , Ugur-sahin , Demetrius-buttelman , Pfizer , Northwell-health , Zacks-investment-research

Widespread infections early in the year weigh on Merck Q1

New era begins at Merck as pandemic cuts Q1 sales, profit
LINDA A. JOHNSON, AP Medical Writer
April 29, 2021
FacebookTwitterEmail
FILE - In this Dec. 18, 2014, file photo, a person walks through a Merck company building in Kenilworth, N.J. COVID-19 infections weighed Merck with so many people avoiding visits to hospitals or even the doctor early in the first quarter. The pharmaceutical company on Thursday, April 29, 2021, reported first-quarter earnings of $3.18 billion.Mel Evans/AP
Merck is entering a new era, with sweeping changes across its executive suite and the spinoff off its women's health and other businesses, a bid to enable both resulting companies to grow faster.

Zacks-investment-research , Merck-co , Zacks-investment , Automated-insights , Kenneth-frazier-business-leader-person , En-frazier , Aroline-litchfield , Ob-davis , Ean-li , Rank-clyburn , Ichael-nally

New era begins at Merck as pandemic cuts Q1 sales, profit

Merck is entering a new era, with sweeping changes across its executive suite and the...

Kenilworth , New-jersey , United-states , Lindaa-johnson , Frank-clyburn , Roger-perlmutter , Rob-davis , Caroline-litchfield , Johnson , Gilead-sciences , Merck-co , Chief-financial-officer-rob-davis